Open AccessExperience with ustekinumab in reservoir Crohn's disease
Author(s) -
María Martínez Burgos,
Isabela Angulo McGrath,
Víctor Amo Trillo,
Raúl Vicente Olmedo Martín,
Patricia Romero,
José Mostazo Torres,
Miguel Jiménez Pérez
Publication year - 2021
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2021.8457/2021
Subject(s) - ustekinumab , medicine , crohn's disease , disease , crohn disease , dermatology , intensive care medicine , pathology , adalimumab
Crohn's disease of the reservoir is a pathology of difficult diagnosis and complex approach due to the scarce documented evidence on it. Recently, studies have been published on the treatment strategies available for this entity. Based on the above, we have analyzed the experience of our center in the treatment of reservoir Crohn's disease with one of the new biologic agents, ustekinumab.